gag, vif, and nef genes contribute to the homologous vital interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: Identification of novel HIV-1-inhibiting viral protein mutants

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 4308-4319

  D'Aloja, Paola ^a   Olivetta, Eleonora ^a   Bona, Roberta ^a   Nappi, Filomena ^a   Pedacchia, Daniela ^a   Pugliese, Katherina ^a   Ferrari, Giuliana ^b   Verani, Paola ^a   Federico, Maurizio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; PRIORITY JOURNAL; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS GENE;

EID: 0031958099     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.4308-4319.1998     Document Type: Article

References (72)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Aiken, C., and D. Trono. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:5048-5056.
3. Aiken, C., J. Konner, N. R. Landau, M. E. Lenburg, and D. Trono. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864.
4. Bernier, R., and M. Tremblay. 1995. Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. J. Virol. 69:291-300.
5. Blanc, D., C. Patience, T. F. Schulz, R. Weiss, and B. Spire. 1993. Transcomplementation of Vif-HIV-1 mutants in CEM cell suggests that Vif affects late steps of the viral life cycle. Virology 193:186-192.
6. Bogerd, H. P., R. A. Fridell, S. Madore, and B. R. Cullen. 1995 Identification of a novel cellular co-factor for the Rev/Rex class of regulatory proteins. Cell 82:485-494.
7. Bona, R., P. d'Aloja, E. Olivetta, A. Modesti, A. Modica, G. Ferrari, P. Verani, and M. Federico. 1997. Aberrant, noninfectious HIV-1 particles are released by chronically infected human T-cells transduced with a retroviral vector expressing an interfering HIV-1 variant. Gene Ther. 4:1085-1092.
8. Borman, A. M., C. Quillent, P. Charneau, C. Dauguet, and F. Clavel. 1995. Human immunodeficiency virus type 1 vif mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69: 2058-2067.
9. Bryant, M. L., L. Ratner, R. J. Duronio, N. S. Kishore, B. Devadas, S. P. Adams, and J. I. Grodon. 1991. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus Gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line. Proc. Natl. Acad. Sci. USA 88:2055-2059.
10. Carlini, F., M. Federico, M. Equestre, S. Ricci, G. Ratti, Qi Zibai, P. Verani, and G. B. Rossi. 1992. Sequence analysis of an HIV-1 proviral DNA from a nonproducer chronically infected Hut-78 cellular clone. J. Viral Dis. 1:40-55.
11. Carlini, F., A. Nicolini, P. d'Aloja, M. Federico, and P. Verani. 1996. The non-producer phenotype of the human immunodeficiency virus type 1 provirus F12/HIV-1 is the result of multiple genetic variations. J. Gen. Virol. 77: 2009-2013.
12. Crise, B., and J. K. Rose. 1992. Human immunodeficiency virus type 1 glycoprotein precursor retains CD4-p56 lck complex in the endoplasmic reticulum. J. Virol. 66:2296-2301.
13. Daly, T. J., K. S. Cook, G. S. Gray, T. E. Maione, and J. R. Rusche. 1989. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 342:816-819.
14. Di Marzio, P., S. Choe, M. Ebright, R. Knoblauch, and N. R. Landau. 1995. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69:7909-7916.
15. di Marzo Veronese, F., T. D. Copeland, A. L. De Vico, R. Rahman, S. Oroszlan, R. C. Gallo, and M. G. Sarnagadharan. 1986. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231:1289-1291.
16. Federico, M., F. Nappi, G. Ferrari, C. Chelucci, F. Mavilio, and P. Verani. 1995. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus. J. Virol. 69:6618-6626.
17. Federico, M., F. Nappi, R. Bona, P. d'Aloja, P. Verani, and G. B. Rossi. 1995. Full expression of transfected nonproducer interfering HIV-1 proviral DNA abrogates susceptibility of human HeLa CD4+ cells to HIV. Virology 206: 76-84.
18. Federico, M., B. Taddeo, F. Carlini, F. Nappi, P. Verani, and G. B. Rossi. 1993. A recombinant retrovirus carrying a nonproducer human immunodeficiency virus (HIV) type 1 variant induces resistance to superinfecting HIV. J. Gen. Virol. 74:2099-2110.
19. Federico, M., F. Titti, S. Buttò, A. Orecchia, F. Carlini, B. Taddeo, B. Macchi, N. Maggiano, P. Verani, and G. B. Rossi. 1989. Biologic and molecular characterization of producer and nonproducer clones from Hut-78 cells infected with a patient HIV isolate. AIDS Res. Hum. Retroviruses 5: 385-396.
20. Feng, Y., C. C. Broder, P. Kennedy, and E. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
21. Fisher, A. G., B. Ensoli, L. Ivanoff, M. Chamberlain, S. Petteway, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-893.
22. Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376:530-533.
23. + lymphocytes. J. Virol. 66:6489-6495.
24. Garcia, J. V., J. Alfano, and A. D. Miller. 1993. The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J. Virol. 67: 1511-1516.
25. Garrett, E. D., L. S. Tiley, and B. R. Cullen. 1991. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J. Virol. 65:1653-1657.
26. Goncalves, J., P. Jallepalli, and D. H. Gabuzda. 1994. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J. Virol. 68: 704-712.
27. Grandgenett, D. P., and G. Goodarzi. 1994. Folding of the multidomain human immunodeficiency virus type-I integrase. Protein Sci. 3:888-897.
28. Green, M., M. Ishino, and P. M. Loewenstein. 1989. Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58:215-223.
29. Haurer, C. A., R. Getty, and M. L. Tyrocinski. 1989. Epstein-Barr virus episome-based promoter function in human myeloid cells. Nucleic Acids Res. 17:1989-2003.
30. Heaphy, S., C. Dingwall, I. Ernberg, and M. J. Gait, S. M. Green, J. Karn, A. D. Lowe, M. Singh, and M. A. Skinner. 1990. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell 60:685-693.
31. Hoglund, S., A. Ohagen, K. Lawrence, and D. Gabudza. 1994. Role of Vif during packing of the core of HIV-1. Virology 201:349-355.
32. Johnson, D., A. Lanahan, C. R. Buck, A. Seghal, C. Morgan, E. Mercer, M. Bothwell, and M. Chao. 1986. Expression and structure of the human NGF receptor. Cell 47:545-554.
33. 2 + M phase of the cell cycle. J. Virol. 69:6304-6313.
34. Karacostas, V., K. Nagashima, M. A. Gonda, and B. Moss. 1989. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86:8964-8967.
35. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehegal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
36. Lavallée, C., and E. A. Cohen. 1993. HIV-1 HxBc2 strain encodes a truncated vpr gene product of 78 amino acids. J. Acquired Immune Defic. Syndr. 6: 529-539.
37. Liu, H., X. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69: 7630-7638.
38. Malim, M. H., W. W. Freimuth, J. Liu, T. J. Boyle, H. K. Lyerly, B. R. Cullen, and G. J. Nabel. 1992. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176:1197-1201.
39. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
40. Matsushita, S. M., M. Robert-Guroff, A. Koito, T. Hattori, H. Hoshino, K. Javaherian, K. Takatsuki, and S. Putney. 1988. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62:2107-2114.
41. Mavilio, F., G. Ferrari, S. Rossini, N. Nobili, C. Bonini, G. Casorati, C. Traversari, and C. Bordignon. 1994. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83:1988-1997.
42. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell line to avoid recombinant leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
43. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-982.
44. Miller, A. D., M. T. Warmerdam, K. A. Page, M. B. Feinberg, and W. C. Greene. 1995. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69:579-584.
45. Miller, M. D., M. T. Warmerdam, I. Gaston, W. C. Greene, and M. B. Feinberg. 1994. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:101-113.
46. Modesti, N., J., Garcia, C. Debouck, M. Peterlin, and R. Gaynor. 1991. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression. New Biol. 3:759-768.
47. Niederman, T. M. J., J. V. Garcia, W. R. Hastings, S. Luria, and L. Ratner. 1992. Human immunodeficiency virus type 1 Nef protein inhibits NF-kB induction in human T cells. J. Virol. 66:6213-6219.
48. Pandori, M. W., N. J. S. Fitch, H. M. Craig, D. D. Richman, C. A. Spina, and J. C. Guatelli. 1996. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70:4283-4290.
49. Porter, D. C., L. R. Melsen, R. W. Compans, and C. D. Morrow. 1996. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag. J. Virol. 70:2643-2649.
50. Purcell, D. F. J., and M. A. Martin. 1993. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67:6365-6378.
51. Rein, A., and A. Schultz. 1984. Different recombinant murine leukemia viruses use different cell surface receptors. Virology 136:144-152.
52. Rossi, G. B., P. Verani, B. Macchi, M. Federico, A. Orecchia, L. Nicoletti, S. Buttò, A. Lazzarin, G. Mariani, G. Ippolito, and V. Manzari. 1987. Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individuals. Ann. N.Y. Acad. Sci. 511:390-400.
53. Rsuche, J. R., D. L. Lynn, M. Robert-Guroff, A. J. Langlosis, H. K. Lyerly, H. Carson, K. Krohn, A. Ranki, R. C. Gallo, D. P. Bolognesi, S. D. Putney, and T. J. Matthews. 1987. Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proc. Natl. Acad. Sci. USA 84:6924-6928.
54. Sakai, H., R. Shibata, J. I. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1663-1667.
55. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
56. Schubert, U., K. A. Clouse, and K. Strebel. 1995. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69:7699-7711.
57. Simm, M., M. Shahabuddin, W. Chao, J. S. Allan, and D. J. Volsky. 1995. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J. Virol. 69:4582-4586.
58. gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into virus-like particles. J. Virol. 64:2743-2750.
59. Sova, P., and D. J. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
60. Spina, C. A., T. J. Kwoh, M. Y. Chowers, J. C. Guatelli, and D. D. Richman. 1994. The importance of Nef in the induction of human immunodeficiency virus type 1 replication for primary quiescent CD4 lymphocytes. J. Exp. Med. 179:115-123.
61. Steck, F., and H. Rubin. 1966. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. Virology 29:628-641.
62. Steck, F., and H. Rubin. 1966. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. II. Early steps of infection by RSV or cells under conditions of interference. Virology 29:642-653.
63. Steffy, K. R., and F. Wong-Staal. 1993. Tansdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant. J. Virol. 67:1854-1859.
64. Stevenson, M., C. Meier, A. M. Mann, N. Chapman, and A. Waslak. 1989. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell 83:483-486.
65. Swingler, S., G. Gallay, D. Camaur, J. Song, A. Abo, and D. Trono. 1997. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J. Virol. 71:4372-4377.
66. Taddeo, B., M. Federico, F. Titti, G. B. Rossi, and P. Verani. 1993. Homologous superinfection of both producer and nonproducer HIV-infected cells is blocked at a late retrotranscription step. Virology 194:441-452.
67. Trono, D., M. B. Feinberg, and D. Baltimore. 1989. HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59: 113-120.
68. Vicenzi, E. Personal communication.
69. Vogt, P. K., and R. Ishizaki. 1965. Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chicken. Virology 26:664-672.
70. Volsky, D. J., M. Simm, M. Shahabuddin, G. Li, W. Chao, and M. J. Potash. 1996. Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. J. Virol. 70: 3823-3833.
71. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
72. Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silverstein, and R. Awel. 1979. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:758-777.